Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vyome Holdings (HIND) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Vyome Holdings (HIND) over the last 11 years, with Q3 2025 value amounting to $5.7 million.

  • Vyome Holdings' Cash & Equivalents rose 57698.84% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year increase of 57698.84%. This contributed to the annual value of $101904.0 for FY2024, which is 9776.48% down from last year.
  • Vyome Holdings' Cash & Equivalents amounted to $5.7 million in Q3 2025, which was up 57698.84% from $4.2 million recorded in Q2 2025.
  • Vyome Holdings' Cash & Equivalents' 5-year high stood at $40.2 million during Q2 2021, with a 5-year trough of $12000.0 in Q2 2024.
  • Its 5-year average for Cash & Equivalents is $8.8 million, with a median of $4.6 million in 2023.
  • In the last 5 years, Vyome Holdings' Cash & Equivalents crashed by 9974.29% in 2024 and then skyrocketed by 3509166.67% in 2025.
  • Vyome Holdings' Cash & Equivalents (Quarter) stood at $22.8 million in 2021, then tumbled by 82.66% to $4.0 million in 2022, then increased by 15.27% to $4.6 million in 2023, then crashed by 97.76% to $101904.0 in 2024, then surged by 5500.38% to $5.7 million in 2025.
  • Its Cash & Equivalents was $5.7 million in Q3 2025, compared to $4.2 million in Q2 2025 and $2.6 million in Q1 2025.